Generalized purpuric drug exanthem with hemorrhagic plaques following bendamustine chemotherapy in a patient with B-prolymphocytic leukemia

International Journal of Hematology

Volumn 95, Issue 3, 2012, Pages 311-314

  Gavini, Aruna ^a   Telang, Gladys H ^b   Olszewski, Adam J ^b  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Bendamustine; Chronic lymphoid leukemia; Drug eruption; Prolymphocytic leukemia; Vasculitis

Indexed keywords

BENDAMUSTINE;

AGED; ARTICLE; B PROLYMPHOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CASE REPORT; CELL INFILTRATION; CYTOPENIA; DRUG ERUPTION; DYSPNEA; EOSINOPHIL; FEMALE; HUMAN; LEG EDEMA; LEUKOCYTOCLASTIC VASCULITIS; LYMPHOCYTOSIS; MACULOPAPULAR RASH; NEUTROPENIA; PROLYMPHOCYTIC LEUKEMIA; PURPURA; SIDE EFFECT; SKIN BIOPSY; SPLENOMEGALY; THROMBOCYTOPENIA; WEIGHT REDUCTION;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOPSY; DRUG ERUPTIONS; EXANTHEMA; FEMALE; HUMANS; LEUKEMIA, PROLYMPHOCYTIC, B-CELL; NITROGEN MUSTARD COMPOUNDS; PURPURA; SKIN; TREATMENT OUTCOME;

EID: 84863006584     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1012-2     Document Type: Article

References (17)

1. Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990;33:1065-7. (Pubitemid 20273289)
2. Dungarwalla M, Matutes E, Dearden CE. Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. Eur J Haematol. 2008;80:469-76. (Pubitemid 351677465)
3. Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001;115:571-81. (Pubitemid 32275950)
4. Lens D, De Schouwer PJ, Hamoudi RA, Abdul-Rauf M, Farahat N, Matutes E, et al. p53 abnormalities in B-cell prolymphocytic leukemia. Blood. 1997;89:2015-23. (Pubitemid 27132117)
5. Robak T, Robak P. Current treatment options in prolymphocytic leukemia. Med Sci Monit. 2007;13:RA69-80. (Pubitemid 46557765)
6. Leoni LM, Bailey B, Reifert J, Bendall HH, Zeller RW, Corbeil J, et al. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res. 2008;14:309-17. (Pubitemid 351378007)
7. Knauf WU, Lissichkov T, Aldaoud A, Liberati A, Loscertales J, Herbrecht R, et al. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. J Clin Oncol. 2009;27:4378-84.
8. Roué G, López-Guerra M, Milpied P, Pérez- Galán P, Villamor N, Montserrat E, et al. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspaseindependent signaling. Clin Cancer Res. 2008;14:6907-15.
9. Stilgenbauer S, Zenz T. Understanding and managing ultra highrisk chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2010;2010:481-8.
10. Treanda [package insert]. Frazer: Cephalon, Inc. 2008.
11. Ramdial PK, Naidoo DK. Drug-induced cutaneous pathology. J Clin Pathol. 2009;62:493-504.
12. Ardern-Jones MR, Friedmann PS. Skin manifestations of drug allergy. Br J Clin Pharmacol. 2011;71:672-83.
13. Alamdari HS, Pinter-Brown L, Cassarino DS, Chiu MW. Severe cutaneous interface drug eruption associated with bendamustine. Dermatol Online J. 2010;16:1.
14. Gerson D, Sriganeshan V, Alexis JB. Cutaneous drug eruptions: a 5-year experience. J Am Acad Dermatol. 2008;59:995-9.
15. Ghersetich I, Comacchi C, Jorizzo JL, Katsambas A, Lotti TM. Proposal for a working classification of cutaneous vasculitis. Clin Dermatol. 1999;17:499-503.
16. Hautmann G, Campanile G, Lotti TM. The many faces of cutaneous vasculitis. Clin Dermatol. 1999;17:515-31.
17. Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol. 2011;36:6-11.